-
Unlocking the potential conjugates for cancer therapy Nature Reviews Clinical
-
Current LC-MS-based strategies for and quantification of antibody-drug conjugates ScienceDirect
-
Recent advances of drug conjugates for applications -
-
Synthesis of site-specific antibody-drug conjugates ADP-ribosyl cyclases
-
Unlocking the potential conjugates for cancer therapy Nature Reviews Clinical
-
Site-selective modification strategies in conjugates - Society Reviews (RSC DOI:10.1039/D0CS00310G
-
Unlocking the potential conjugates for cancer therapy Nature Reviews Clinical
-
Site-selective modification strategies in conjugates - Society Reviews (RSC DOI:10.1039/D0CS00310G
-
Clinical of Antibody-drug Conjugates » ADC
-
and challenges for the next generation of antibody–drug conjugates | Nature Reviews Drug Discovery
-
Pharmaceuticals | Free | Analytical Methods for Detection Quantification of ADCs in Biological Matrices |
-
and challenges for the next generation of antibody–drug conjugates | Nature Reviews Drug Discovery
-
Conjugate, a Trojan Horse to Fight Cancer
-
Recent advances the construction conjugates Nature Chemistry
-
Antibody-drug recent conjugation and linker chemistries | SpringerLink
-
Uncialamycin-based antibody–drug conjugates: Unique ADCs bystander killing effect | PNAS
-
Computationally designed antibody–drug conjugates self-assembled affinity ligands | Nature Biomedical Engineering
-
Site-selective modification strategies in conjugates - Society Reviews (RSC DOI:10.1039/D0CS00310G
-
Systematic identification of engineered methionines and oxaziridines for efficient, stable, site-specific antibody bioconjugation PNAS
-
Approved Antibody-Drug Conjugates Up 2021 |
-
Site-selective modification strategies in conjugates - Society Reviews (RSC DOI:10.1039/D0CS00310G
-
Unlocking the potential conjugates for cancer therapy Nature Reviews Clinical
-
and challenges for the next generation of antibody–drug conjugates | Nature Reviews Drug Discovery
-
1 Introduction to Antibody–Drug Conjugates (ADCs) DOI:10.1039/9781788012898-00001
-
Approved Antibody-Drug Conjugates Up 2021 |